What is the cost of Clevatess per pill?

What is the cost of Clevatess per pill?

The cost of Clevatess per pill typically ranges from $8 to $15 per tablet, depending on several factors including your pharmacy, insurance coverage, and geographic location within the United States.

Factors Affecting Clevatess Pricing

Insurance Coverage: Most commercial insurance plans and Medicare Part D cover Clevatess (elacestrant), though your out-of-pocket cost will depend on your specific plan's formulary tier and copay structure. Patients with insurance may pay significantly less than the retail price.

Pharmacy Choice: Different pharmacies may offer varying prices for Clevatess. Chain pharmacies, independent pharmacies, and specialty pharmacies often have different pricing structures, so it's worth comparing options in your area.

Geographic Location: Medication costs can vary by state and region, with some areas experiencing higher overall pharmaceutical pricing than others.

Cost-Saving Options

Patient Assistance Programs: Stemline Therapeutics, the manufacturer of Clevatess, offers patient support programs that may help reduce costs for eligible patients, including those who are uninsured or underinsured.

Specialty Pharmacy Networks: Since Clevatess is often dispensed through specialty pharmacies, these facilities may offer dedicated financial counseling services to help patients navigate insurance benefits and identify cost-reduction opportunities.

Monthly Treatment Costs

With a typical dosing schedule of one 345mg tablet daily, patients can expect monthly costs ranging from $240 to $450 before insurance coverage or assistance programs are applied.

Getting Accurate Pricing

For the most current and personalized pricing information, contact your prescribing oncologist's office or speak directly with your preferred pharmacy. They can provide specific cost estimates based on your insurance plan and available discounts. Many healthcare providers also work closely with financial counselors who specialize in cancer medication access and affordability.